Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C-Reference-Cited by-同舟云学术

Efficacy and safety of treatment with interferon-α2b plus ribavirin in children with chronic hepatitis C

Published:2006-06 Issue:6 Volume:3 Page:316-317
ISSN:1743-4378
Container-title:Nature Clinical Practice Gastroenterology & Hepatology
language:en
Short-container-title:Nat Rev Gastroenterol Hepatol

Author:

Mozer-Lisewska Iwona

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Hepatology,General Medicine

Link

http://www.nature.com/articles/ncpgasthep0495.pdf

Reference5 articles.

1. Wirth S et al. (2002) Recombinant alfa-interferon plus ribavirin therapy in children and adolescents with chronic hepatitis C. Hepatology 36: 1280–1284

2. Kowala-Piaskowska A et al. (2005) Factors influencing early virological response in children with chronic viral hepatitis C treated with pegylated interferon and ribavirin. Hepatol Res 32: 224–226

3. Manns MP et al. (2001) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomized trial. Lancet 358: 958–9654

4. Mozer-Lisewska I et al. (2003) Virus genotype 1b and long-term response to interferon alpha monotherapy in children with chronic hepatitis C. Eur J Pediatr 162: 755–759

5. Bruno S et al. (2004) Peginterferon alfa-2b plus ribavirin for naive patients with genotype 1 chronic hepatitis C: a randomized controlled trial. J Hepatol 41: 474–481

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current awareness: Pharmacoepidemiology and drug safety;Pharmacoepidemiology and Drug Safety;2006